JP2022553700A5 - - Google Patents

Info

Publication number
JP2022553700A5
JP2022553700A5 JP2022523558A JP2022523558A JP2022553700A5 JP 2022553700 A5 JP2022553700 A5 JP 2022553700A5 JP 2022523558 A JP2022523558 A JP 2022523558A JP 2022523558 A JP2022523558 A JP 2022523558A JP 2022553700 A5 JP2022553700 A5 JP 2022553700A5
Authority
JP
Japan
Prior art keywords
phenyl
carboxamide
dihydro
oxo
benzodiazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022523558A
Other languages
English (en)
Japanese (ja)
Other versions
JP7667778B2 (ja
JP2022553700A (ja
Filing date
Publication date
Priority claimed from GB201915273A external-priority patent/GB201915273D0/en
Application filed filed Critical
Publication of JP2022553700A publication Critical patent/JP2022553700A/ja
Publication of JP2022553700A5 publication Critical patent/JP2022553700A5/ja
Application granted granted Critical
Publication of JP7667778B2 publication Critical patent/JP7667778B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022523558A 2019-10-22 2020-10-22 呼吸器合胞体ウイルス(rsv)感染症を治療するためのベンゾジアゼピン誘導体 Active JP7667778B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1915273.5 2019-10-22
GB201915273A GB201915273D0 (en) 2019-10-22 2019-10-22 Pharmaceutical compounds
PCT/GB2020/052658 WO2021079121A1 (en) 2019-10-22 2020-10-22 Benzodiazepine derivatives for treating a respiratory syncytial virus (rsv) infection

Publications (3)

Publication Number Publication Date
JP2022553700A JP2022553700A (ja) 2022-12-26
JP2022553700A5 true JP2022553700A5 (cg-RX-API-DMAC7.html) 2023-10-23
JP7667778B2 JP7667778B2 (ja) 2025-04-23

Family

ID=68728299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022523558A Active JP7667778B2 (ja) 2019-10-22 2020-10-22 呼吸器合胞体ウイルス(rsv)感染症を治療するためのベンゾジアゼピン誘導体

Country Status (8)

Country Link
US (1) US20220409629A1 (cg-RX-API-DMAC7.html)
EP (1) EP4048665A1 (cg-RX-API-DMAC7.html)
JP (1) JP7667778B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220097420A (cg-RX-API-DMAC7.html)
CN (1) CN114761397B (cg-RX-API-DMAC7.html)
CA (1) CA3158169A1 (cg-RX-API-DMAC7.html)
GB (1) GB201915273D0 (cg-RX-API-DMAC7.html)
WO (1) WO2021079121A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201911944D0 (en) 2019-08-20 2019-10-02 Reviral Ltd Pharmaceutical compounds
GB201915932D0 (en) 2019-11-01 2019-12-18 Reviral Ltd Pharmaceutical compounds
GB202010409D0 (en) 2020-07-07 2020-08-19 Reviral Ltd Pharmaceutical compounds
WO2024252355A1 (en) 2023-06-08 2024-12-12 Pfizer Inc. Pediatric dosing regimens comprising a fusion inhibitor for the treatment of rsv
WO2025120500A1 (en) 2023-12-06 2025-06-12 Pfizer Inc. Benzodiazepine compounds as n-protein inhibitors
CN122580320A (zh) 2024-01-16 2026-08-14 辉瑞大药厂 作为n-蛋白抑制剂的苯二氮䓬吡唑甲酰胺类

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0314595A (pt) * 2002-09-20 2005-08-09 Arrow Therapeutics Ltd Uso de um derivado de benzodiazepina ou um sal farmaceuticamente aceitável deste, inalador ou nebulisador, produto, usos de um produto e de um composto ou sal farmaceuticamente aceitável deste, derivado de benzodiazepina, composto, e, composição farmacêutica
GB0221923D0 (en) * 2002-09-20 2002-10-30 Arrow Therapeutics Ltd Chemical compounds
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
US20070293482A1 (en) * 2004-03-19 2007-12-20 Novartis Pharmaceuticals Corporation Process for Preparing Benzodiazepines
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
CA2622592A1 (en) * 2005-09-19 2007-03-29 Arrow Therapeutics Limited Benzodiazepine derivatives for treating hepatitis c infection
US8871756B2 (en) * 2011-08-11 2014-10-28 Hoffmann-La Roche Inc. Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
GB201506448D0 (en) 2015-04-16 2015-06-03 Univ Durham An antimicrobial compound
MY197231A (en) * 2015-07-22 2023-06-06 Enanta Pharm Inc Benzodiazepine derivatives as rsv inhibitors
GB201613942D0 (en) 2016-08-15 2016-09-28 Univ Of Durham The An antimicrobial compound
WO2018129287A1 (en) 2017-01-06 2018-07-12 Enanta Pharmaceuticals, Inc. Heteroaryldiazepine derivatives as rsv inhibitors
WO2018226801A1 (en) 2017-06-07 2018-12-13 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as rsv inhibitors
WO2020190935A1 (en) * 2019-03-18 2020-09-24 Enanta Pharmaceuticals, Inc. Benzodiazepine derivatives as rsv inhibitors
GB201911944D0 (en) * 2019-08-20 2019-10-02 Reviral Ltd Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP2020183410A5 (cg-RX-API-DMAC7.html)
JP2021119196A5 (cg-RX-API-DMAC7.html)
JP2023533447A5 (cg-RX-API-DMAC7.html)
JP2022551422A5 (cg-RX-API-DMAC7.html)
JP2023549187A5 (cg-RX-API-DMAC7.html)
JP2005526028A5 (cg-RX-API-DMAC7.html)
JP2022501429A5 (cg-RX-API-DMAC7.html)
EP2785713A1 (en) Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
JP2018514544A5 (cg-RX-API-DMAC7.html)
NZ579403A (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
RU2007127834A (ru) Производные 1, 6-замещенного (3r, 6r)-3-(2, 3-дигидро-1н-инден-2-ил)-2, 5-пиперазиндиона в качестве антагонистов рецептора окситоцина для лечения преждевременных родов, дисменореи и эндометриоза
JP2021535134A5 (cg-RX-API-DMAC7.html)
JP2022511477A5 (cg-RX-API-DMAC7.html)
JP2022546410A5 (cg-RX-API-DMAC7.html)
RU2006145205A (ru) Терапевтические соединения: пиридин в качестве каркаса
CN101778633A (zh) 二肽基肽酶抑制剂的每周给药
JP2022501434A5 (cg-RX-API-DMAC7.html)
JP2011530593A5 (cg-RX-API-DMAC7.html)
JP2021535137A5 (cg-RX-API-DMAC7.html)
CN114761397A (zh) 用于治疗呼吸道合胞病毒(rsv)感染的苯并二氮䓬衍生物
CN109415358A (zh) 作为RORγt调节剂的6-氨基吡啶-3-基噻唑
HUT68445A (en) Antiviral nucleoside analogues
JP2022522890A5 (cg-RX-API-DMAC7.html)
JP2024041835A (ja) 置換テトラヒドロシクロペンタ[c]ピロール、置換ジヒドロピロリジン、その類似体、およびそれらを使用する方法
RU2011105059A (ru) Применение производных пиримидиламинобензамида для лечения фиброза